Skip to main content
Premium Trial:

Request an Annual Quote

He'll Be Under the Desk

NCI director John Niederhuber would like to stay on at his post, says the Wall Street Journal Health blog. Niederhuber told The Cancer Letter that his resignation letter to be submitted at the end of the Bush administration will say that he is willing to continue on in the Obama administration, even as an intramural scientist or a lower-level administrator. "It's a big place. I can easily hide," Niederhuber tells The Cancer Letter.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.